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BACKGROUND: An effective embryonic–maternal interaction is crucial for successful human pregnancy. Failure of
this process is a major cause of infertility and can lead to placental dysfunction resulting in recurrent miscarriage, fetal
retardation and pre-eclampsia. Research is severely constrained by ethical and practical considerations; therefore, we
aimed to generate cytotrophoblast stem (CTBS) cell lines from human embryonic stem cells (HESCs). METHOD: b-
HCG was used as a marker of viable trophoblast cells. In defined culture, embryoid bodies were generated from HESCs
and selected for trophoblast enrichment by rounds of cellular aggregation and disaggregation. Distinct CTBS cell lines
were isolated and characterized. Spheroid cytotrophoblast bodies were generated and their interaction with luteal-
phase endometrial stroma was analysed by real-time image analysis. RESULTS: Three CTBS cell lines were derived,
which were maintained in the absence of residual HESCs, fibroblast feeder cells or extracellular matrix. CTBS cells dis-
played typical cytotrophoblast and syncytiotrophoblast characteristics and exhibited further differentiation to invasive
endovascular cell phenotype. One cell line was generated with constitutive expression of enhanced green fluorescent
protein (eGFP). Spheroid trophoblast bodies mimicked closely the early invasive stages of implantation when incubated
with human endometrial stromal preparations in vitro. CONCLUSION: These human CTBS cell lines are a significant
new model for investigating human placentation and may have considerable potential in cell therapy applications.
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Introduction
The continual proliferation of trophoblast stem cells (TS) by
the blastocyst and post-implantation embryo is of critical
importance for the maintenance of pregnancy (Paria et al.,
2002; Red-Horse et al., 2004). Initially, the rapidly dividing
trophoblast cells generate syncytiotrophoblast by cell fusion.
This terminally differentiated and nondividing syncytium
penetrates the endometrial epithelium to invade underlying
endometrial stroma where it forms a contiguous layer at the
interface with maternal tissue and provides a primary barrier to
protect the embryo from immune rejection. Syncytiotrophob-
last also synthesizes and secretes HCG, a peptide hormone that
prevents regression of the corpus luteum, thereby maintaining
progesterone levels for uterine function and pregnancy. Extensive
proliferation and differentiation of cytotrophoblast following
initial implantation is responsible for the subsequent formation
of the primate haemochorial placenta. In particular, differentia-
tion of cytotrophoblast to invasive extravillous trophoblast and
endovascular phenotypes enables the invasion and colonization
of uterine spiral arterioles which are remodelled to allow much
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greater maternal blood flow for the continuation of fetal devel-
opment and growth. Endovascular cells also express membrane
and soluble HLA-G, the nonclassical histocompatibility antigen
believed to be involved in immune tolerance of the fetus
(Le Bouteiller et al., 2003). Aberrant development of trophoblast
(including defective HLA-G function) is associated with serious
complications, including recurrent miscarriage, pre-eclampsia
and restricted fetal growth (Paria et al., 2002; Laird et al.,
2003; Red-Horse et al., 2004). Recently, elevated HLA-G
secretion from the preimplantation blastocyst has been corre-
lated with successful pregnancy outcome after assisted repro-
duction techniques (Noci et al., 2005; Yie et al., 2005).
The process of trophoblast differentiation is poorly under-
stood in women because investigations are severely constrained
by ethical and practical considerations.
Various cell lines have been generated from normal, malignant
or transformed (immortalized) trophoblast and placental tis-
sues, and these have provided useful in vitro models to investi-
gate placental development and function (King et al., 2000).
However, many of these cell lines originate from late stage or
term placental tissues or have lost functional capacity after
transformation and therefore fail to recapitulate the physiology
of trophoblast during the peri-implantation stages of develop-
ment. Hence, we sought to generate human cytotrophoblast
stem (CTBS) cell lines as a renewable source of progenitor tro-
phoblast cells to serve in model systems of implantation.
In the mouse, TS cells isolated from pre- and post-implantation
embryos can be maintained indefinitely in culture and have the
capacity to differentiate along the trophoblast lineage (Tanaka
et al., 1998). However, so far the derivation of human TS cells
from preimplantation blastocysts has not been achieved, high-
lighting the differences in early embryo and placental develop-
ment between these species (Henderson et al., 2002).
Therefore, we investigated the use of human embryonic stem
cells (HESCs) as a route to obtaining TS cell population.
Although HESCs differentiate spontaneously to trophoblast-
like cells in culture (Thomson et al., 1998; Draper et al., 2002),
when supplemented with bone morphogenetic protein 4 (Xu
et al., 2002) or when Oct-4 is down-regulated (Matin et al.,
2004), these cells are terminally differentiated and display a
limited proliferative capacity. Trophoblast differentiation can
develop further when HESCs are aggregated to form embryoid
bodies (EBs), but residual HESCs and other cell types in
the culture resulting from spontaneous differentiation can con-
found the findings from these preparations (Gerami-Naini
et al., 2004). We surmised that the proportion of trophoblast
cells that developed in human EBs in vitro would vary and
sought to identify viable EBs containing trophoblast cells by
measuring the secretion of the β-subunit of HCG (β-HCG) as
secreted by syncytiotrophoblast. Such EBs might potentially
contain a CTBS cell population for enrichment and purification.
Materials and methods
Materials
Human embryonic stem cell medium (HES medium) was prepared as
described previously (Matin et al., 2004). Unless stated otherwise,
media and reagents were from Invitrogen (Paisley, UK) and antibod-
ies from Sigma-Aldrich (Poole, UK).
HESC maintenance, differentiation and trophoblast enrichment
HESCs (H7 and H14, University of Wisconsin) of normal karyotype
were maintained and passaged by standard protocols (Henderson et al.,
2002; Matin et al., 2004). Batches of EBs were usually prepared from
three T25 flasks of HESCs (dissociated with 1 mg/ml collagenase IV)
and placed in HES medium (Thomson et al., 1998) without basic fibrob-
last growth factor (FGF) in Petri dishes in 5% CO2 in air. HESCs did not
adhere to the Petri dish surface and instead aggregated to form EBs. On
day 5, well-formed spherical EBs of approximately the same diameter
(approximately 200 μm) were transferred singly to wells of a 96-well
culture plate and cultured for a further 3 days before aliquots of medium
were subjected to enzyme-linked immunosorbent assay (ELISA) as
described previously (Acevedo et al., 1997; Nishimura et al., 1989).
To select for CTBS cells, EBs exhibiting high levels of β-HCG
secretion were subjected to several rounds of selective enrichment by
growth in conditioned ‘TS’ medium as described by Tanaka et al.
(1998) for differentiation of murine TS cells from extraembryonic
ectoderm. TS medium comprised Roswell Park Memorial Institute
(RPMI) 1640 medium supplemented with 20% fetal calf serum, 1 mm
sodium pyruvate, 100 μm β-mercaptoethanol, 2 mM L-glutamine and
supplemented with fibroblast growth factor 4 (FGF4) and heparin.
The medium was conditioned by incubation with confluent T25 flasks
of mouse embryonic fibroblast (density of 5 × 106 per flask) for 72 h,
filtered and stored at –20°C until used. This conditioned medium was
diluted with fresh nonconditioned medium at a ratio of 70 : 30. Those
EBs maintaining a high secretion of β-HCG were pooled, disaggre-
gated and allowed to form new EBs, and this enrichment protocol was
repeated consecutively for three rounds until all EBs displayed con-
sistently high β-HCG secretion. EBs were disaggregated (0.25%
trypsin-EDTA) and then single cells allowed to proliferate in adherent
culture in TS medium without feeders. Medium was changed daily,
and cells were passaged every 5 days by splitting 1 : 4 from T25
flasks. Density of cells was 1–2 × 106 per flask.
Cell lines were cryopreserved using the freezing medium of fetal
calf serum supplemented with 10% dimethylsulphoxide (DMSO).
Briefly, the medium was removed from the flask and cells were
washed with 5 ml PBS before the addition of trypsin-EDTA solution
for 5 min. Complete medium was added to neutralize the enzyme, and
cells were recovered by aspiration, washed by centrifugation and
resuspended in ice-cold freezing medium in cryovials which were
placed in a polystyrene container overnight at –70°C before transfer to
liquid nitrogen. Vials of cells were thawed at 37°C in a water bath,
and the cells were washed by centrifugation thrice before transfer to
fresh TS medium in a T25 flask.
ELISA determination of b-HCG concentration in cell cultures
Concentrations of β-HCG were determined using a sandwich enzyme
immunoassay kit (DRG Diagnostics, Marburg, Germany). The stan-
dards and samples were incubated with 100 μl antiHCG enzyme con-
jugate for 30 min at room temperature followed by a five-times
washing procedure. A second incubation with 100 μl substrate solution
for 10 min was terminated with the addition of 50 μl stop solution.
Absorbance was read at 450 ± 10 nm with a microtitre plate reader.
The concentration of β-HCG in the samples was determined from the
standard curve as m IU/ml.
Analysis of CTBS cell lines
Trophoblast phenotype of the cell lines were analysed by immunolo-
calization following previously described methods for the pan trophoblast
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marker cytokeratin 7 (Kam et al., 1999; Haigh et al., 1999), stage-spe-
cific embryonic antigen 1 (SSEA1; Henderson et al. 2002) and human
placental lactogen (HPL; King et al. 2000). Additionally, RT–PCR
was performed with primer sequences for marker genes of HESCs and
trophoblast. Total RNA (2 μg) was reverse transcribed using 1 μg
oligo-dT primer with Moloney murine leukaemia virus (MMLV)
Reverse-Transcriptase (Promega, Cowley, UK) in a 40 μl reaction vol-
ume containing 1.25 mM dNTPs at 37°C. PCR was performed using 1
μl of cDNA in 50 μl reaction volume containing 15 pmol of each
primer, 0.2 mM dNTPs and 1 unit Taq polymerase (Promega). Primer
sequences used and conditions of these reactions were as follows:
b-actin-F: 5´-ATCTGGCACCACACCTTCTACAATGAGCTGCG-3´;
b-actin-R: 5´-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3´
(60°C annealing, ×23 cycles).
Oct4-F: 5´-CGACCATCTGCCGCTTTGAG-3´;
Oct4-R: 5´-CCCCCTGTCCCCCATTCCTA-3´ (60°C annealing,
×23 cycles).
Sox2-F: 5´-CCCCCGGCGGCAATAGCA-3´;
Sox2-R: 5´-TCGGCGCCGGGGAGATACAT-3´ (60°C annealing,
×38 cycles).
FGF4-F: 5´-CTACAACGCCTACGAGTCCTACA-3´;
FGF4-R: 5´-GTTGCACCAGAAAAGTCAGAGTTG–3´ (56°C
annealing, ×40 cycles).
Nanog-F: 5´-GCCTCAGCACCTACCTACCC-3´;
Nanog-R: 5´-GGTTGCATGTTCATGGAGTAG-3´ (60 annealing
and ×30 cycles).
Eomes-F: 5´-TCACCCCAACAGAGCGAAGAGG-3´;
Eomes-R: 5´-AGAGATTTGATGGAAGGGGGTGTC-3´ (57°C
annealing, ×35 cycles).
Cdx2-F: 5´-CCTCCGCTGGGCTTCATTCC-3´;
Cdx2-R: 5´-TGGGGGTTCTGCAGTCTTTGGTC-3´ (60°C annealing,
×35 cycles);
HLA-G-F: 5´-GCGGCTACTACAACCAGAGC-3´;
HLA-G-R: 5´-GCACATGGCACGTGTATCTC-3´ (55°C annealing,
×26 cycles).
CD9-F: 5´-TTGGACTATGGCTCCGATTC-3´;
CD9-R: 5´-GATGGCATCAGGACAGGACT-3´ (55°C annealing,
×26 cycles).
CK7-F: 5´-ACAGAGCTGCAGTCCCAGAT-3´;
CK7-R: 5´-GTAGGTGGCGATCTCGATGT-3´ (55°C annealing,
×26 cycles).
Fluorescence-activated cell sorter
Trophoblast cells were prepared for cell sorting by dissociating CTBS
cells into single cells with trypsin-EDTA solution. To block nonspe-
cific binding sites, the cells were resuspended at 5 × 106/ml in fluores-
cence-activated cell sorter (FACS) buffer with 40% normal goat serum
on ice for 20 min. About 90 μl of the cell suspension was aliquoted
into FACS tube, and 10 μl of G233 (marker for HLA-G) and W6/32
HLA class I control was added. G233 supernatant with NaN3 (mouse
IgG2a) was kindly given by Dr Ashley King, University of Cambridge.
The cells were incubated on ice for 30 min and washed twice by cen-
trifugation before being labelled with anti-mouse polyvalent immu-
noglobulin fluorescein isothiocyanate (FITC) conjugate for 30 min on
ice. The cells were washed again and resuspended in 300 μl buffer.
Constitutive expression of enhanced green fluorescent protein 
in HESCs
A pCAG-GFP expression vector was constructed by excision of
enhanced green fluorescent protein (eGFP) from pEGFP-1 (Clontech,
Cowley, UK) with XhoI and NotI and insertion into the pCAG vector
(Niwa et al., 2002). H7 cells were seeded at the equivalent of 2 × 105
per well of a 6-well plate on Matrigel (Becton Dickinson, Cowley,
UK). The next day they were transfected using ExGen 500 (Fermentas,
Hanover, Germany) according to the manufacturer’s instructions. The
DNA/NaCl ExGen mixture was then added directly to the normal
growth medium in the well. The plate was centrifuged at 280 g for 5
min and placed back in the incubator. The medium was exchanged the
next day with HES growth medium containing puromycin (at 1 μg/
ml). Viable colonies were picked after 2–3 weeks.
Endometrial–CTBS spheroid co-culture
The invasive implantation potential of the CTBS cell lines was exam-
ined using spheroid culture. This technique has been shown to main-
tain extravillous cytotrophoblast phenotype of first trimester placental
tissue (Korff et al., 2004). Aggregates of CTBS cells were generated
in a similar manner to EBs from confluent monolayers (three T25
flasks) following brief trypsinization and incubation in nonadherent
(Petri dish) culture for 5–10 days, where they formed spheroid tro-
phoblast bodies (TBs). These TBs were explanted to Matrigel culture
in TS medium or to endometrial stromal co-culture. For the latter,
luteal-phase endometrial biopsies were obtained from women under-
going hysterectomy under full ethical approval and patient consent.
Endometrial epithelial and stromal cells were isolated as described
previously (Laird et al., 1993). Preparations were embedded in
Matrigel on membrane inserts and primed with progesterone for 24 h
before the start of co-culture with CTBS. In monolayer co-culture,
TBs were cultured on a confluent layer of stromal or epithelial cells in
culture wells. The co-cultures were maintained in 500 μl of either con-
ditioned TS medium or serum-free HES medium up to 6 days.
Time-lapse microscopy
CTBS cultures or TB–endometrial co-cultures were continuously
monitored under an inverted microscope in a humidified physiological
chamber at 37°C in 5% CO2 in air for up to 3 days. Preliminary exper-
iments indicated no difference in the viability of cells maintained
under these conditions compared with a standard incubator. Regions
of interest (ROI) were identified and programmed for analysis using
Simple PCI software (Digital Pixel, Brighton, UK) with control over
xyz scan, transmitted light and image capture. Routinely 20 ROIs
were identified with image capture every 15 min.
Results
Derivation of CTBS cell lines
Trophoblast-containing EBs were first prepared by aggregation
of single HESCs in ES medium without basic FGF in nonad-
herent Petri dish culture (5 days) and then transferred singly to
wells of a 96-well culture plate (3 days). β-HCG was detected
in most wells (4 × 96 well plates), but only 3.8% of the wells
had concentration of hormone greater than 500 m IU/ml
(Figure 1A). The EBs in these wells were of equivalent size
and morphology, indicating that any increase in β-HCG was
most likely due to the proportion of trophoblast cells rather
than a greater overall number of cells. Control cultures of EBs
in HES medium without basic FGF exhibited only basal
β-HCG levels (<50 m IU/ml) indicating poor trophoblast dif-
ferentiation. Thereafter, EBs selected initially (i.e. displaying
β-HCG levels above 500 m IU/ml) were pooled, disaggre-
gated and re-aggregated and subjected to culture in TS
medium. After three rounds of culture, all EBs secreted high
levels of β-HCG and were subjected to adherent culture con-
ditions. Four cell lines were generated initially, but two lines
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failed to proliferate after passages 8 and 12. The remaining
two lines have retained persistent proliferative capacity for
more than 30 passages (CTBS1 from H7 HESC and CTBS2
from H14 HESC) and form epithelial-like cell colonies with
single and multinucleated cells (Figure 1B). An additional
CTBS cell line (CTBS–GFP1) was generated by the same
Figure 1. Derivation and initial characterization of human cytotrophoblast stem (CTBS) cell lines; bars = 20 μm throughout. (A) Histogram of β-
HCG concentration in culture medium in 96-wells containing single embryoid bodies. (B) Adherent epithelial CTBS cells in ‘trophoblast stem
(TS) cell’ culture without feeder cells. (C) Adherent multinucleated syncytiotrophoblast in same culture as in panel B. (D) and (E) adherent
CTBS cells under phase contrast and UV light displaying cytokeratin (green) and β-HCG (red/orange) immunolocalization (nucleus, blue). (F)
and (G) single CTBS cells fusing to adherent multinucleated syncytium under phase contrast and UV. Single cells mainly cytokeratin+ and syncy-
tium mainly β-HCG+. (H) Adherent green fluorescent protein (GFP)-syncytial trophoblast (phase contrast and UV) and (I) UV alone. Inset: low
power of GFP-trophoblast vesicles.
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methods but from H7 HESCs with constitutive expression of
eGFP (Figure 1H and I). Continuous proliferation of each cell
line was related to the persistence of a mononuclear cytotro-
phoblast population (relative to syncytium formation) as
determined by immunostaining for cytokeratin and β-HCG
(Figure 1D–G). Cell proliferation was maintained by regular
cell passage every 5 days, because this inhibited terminal
differentiation.
When CTBS cells (CTBS1 and 2) and TBs were returned to
mouse embryonic fibroblast feeders with HES medium they
failed to revert to or generate either HESC colonies or EBs with
pluripotent developmental capacity other than trophoblast.
Characterization of CTBS cell lines
CTBS cells displayed dual immunolocalization of CK7 and
HCG and also expressed HPL and SSEA1. Most (>80%) CTBS
cells were single mononuclear cells which did not form colonies.
However with time in culture before passage, cells fused to form
syncytium (see below). They did not localize antibody markers
to undifferentiated HESCs, namely Tra-1-60, SSEA3 or SSEA4.
The mRNA expression for Oct-4, Sox2, FGF4 and Nanog in the
derived cell lines was absent, but trophoblast-related mRNAs for
Cdx2 (caudal-related homeobox), HLA-G and Cd9 were up-
regulated or for Ck7 was maintained (Figure 2A). Expression of
eomesodermin, a marker of murine post-implantation trophob-
last, was absent in the CTBS cells but present in HESCs.
To further assess the subtype of trophoblast cells, the com-
parative cell surface expression of histocompatibility HLA class
I (pan HLA antibody W6/32) and HLA-G (antibody G233)
antigens was determined by FACS and immunolocalization.
The majority of cells (approximately 90%) expressed HLA
class I histocompatibility antigens (Loke and King, 1995), con-
sistent with extravillous trophoblast (Figure 2B). The expres-
sion of HLA-G was relatively weak in most cells, but a small
proportion (approximately 10%) of cells displayed strong
immunoreactivity (Figure 2B and C). Some cells expressed
vimentin, a marker of interstitial cytotrophoblast (King et al.,
2000).
CTBS cell differentiation to endovascular cell phenotype
Following extended culture for one week or more in T25
flasks, the proportion of HLA-G+ cells increased considerably
(>90%). These cells exhibited distinct endothelial cell mor-
phology similar to cultures of differentiating cytotrophoblast
from first trimester human placental tissue (Nagamatsu et al.,
2004) and also resembling endothelial morphological differen-
tiation from primate embryonic stem cells (Levenberg et al.,
2002; Kaufman et al., 2004). Significantly, however, the cells
co-expressed HLA-G and the platelet endothelial cell adhesion
molecule-1 (PECAM-1), both markers of invasive endovascu-
lar (endothelial-like) cytotrophoblast (Red-Horse et al., 2004)
(Figure 3). Vascular endothelial (VE)-cadherin and E-cadherin
immunolocalization were weak or absent on endovascular cells
but strong on a relatively small proportion (<5%) of multinu-
cleated cells also present at this stage and most likely equival-
ent to the syncytial giant cells found in stroma of the
developing placenta. As determined by RT–PCR, adherent
endovascular trophoblast in culture exhibited PECAM-1
mRNA expression but neither vascular endothelial growth fac-
tor receptor 1 (flt-1) nor VE cadherin exhibited the expression
in comparison with EBs, again distinguishing these cells from
a true endothelial phenotype (Figure 3I).
Functional analysis of CTB cells
To determine their functional capacity, CTBS cells were moni-
tored by continuous time-lapse recording for cell–cell fusion
and the formation of nonproliferative, syncytiotrophoblast
(Paria et al., 2002). Adherent cells displayed progressive
migration across the culture dish promoted by pseudopodia-
like extension of cells. When cells occasionally converged they
fused to form multicellular syncytiotrophoblast cells (Figure
1G) that were β-HCG- and Ck7-positive but HLA class I nega-
tive. This cell fusion was captured unequivocally by digital
time-lapse microscopy. Single cells fusing with each other, sin-
gle cells fusing with multinucleated cells and multinucleated
cells fusing with each other (Figure 4) were all observed.
The invasive implantation potential of the CTBS cell lines
was investigated by generating TBs. When cultured in extracel-
lular matrix (Matrigel) drops, these spheroid aggregates
developed characteristic outgrowths, which expressed β-HCG
and cytokeratin (Figure 5Ai and ii). On further culture with
primary human endometrial tissue (luteal phase), prepared using
well-characterized protocols (Laird et al., 1993), TBs attached to
both epithelial and stromal cells. qSignificantly, as shown by
time-lapse microscopy (Figure 5B), TBs with stromal cell cul-
tures displayed a characteristic circular migratory movement and
exhibited polar outgrowths from which endovascular cells
Figure 2. RT–PCR and fluorescence-activated cell sorter (FACS)
analysis of trophoblast stem (TS) cells. (A) Gene expression (RT–
PCR) for undifferentiated human embryonic stem cells (HESCs) (H7)
and cytotrophoblast stem (CTBS) 1 and 2 cell lines. (B) FACS ana-
lysis profile for CTBS2 (similar data for CTBS1 not shown) in early
culture. A proportion of cells express nonclassical HLA-G (peak A),
whereas the majority express all forms of HLA class I. (C) Phase con-
trast and immunofluorescent labelling of cells used for FACS analysis
indicating HLA-G staining; bar = 20 μm.
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streamed. After about 24–36 h in co-culture, these trophoblast
outgrowths were the site of erosion of the extracellular matrix of
the stroma. This was identified by the rapid retraction of the tro-
phoblast vesicle owing to the dissolution of underlying extracel-
lular matrix of the stromal cells (Figure 5B2–5). The erosion site
was characterized by extravillous (HLA–G+) trophoblast that
expressed matrix metalloproteinase (MMP)-2 (gelatinase A;
Figure 5B4i and ii); single GFP-trophoblast cells with endome-
trial stroma in culture displayed a similar response.
Discussion
As far as we are aware, these are the first human CTBS cell
lines to be derived from HESCs and then maintained independ-
ently without feeder cells. Although trophoblast cells can be
derived directly from HESCs (Xu et al., 2000; Matin et al.,
2004), they rapidly lose proliferative capacity after forming
syncytium, and any self-renewing progenitor CTBS population
is lost. In the mouse, trophoblast cells proliferate in response to
FGF4 via their FGFR2 receptor (Tanaka et al., 1998), and a
stem cell population can be generated. Therefore, we used TS
medium containing FGF4 and heparin to maintain CTBS cells
derived from HESCs, which could be subsequently enriched,
and selected for, to create three cell lines. These CTBS cell
lines differ from many of the immortalized placental lines
(Pavan et al., 2003; Feng et al., 2005) in that they have
multipotent capacity to differentiate to various trophoblast phe-
notypes including syncytiotrophoblast and extravillous
cytotrophoblast. This differentiation process is initiated in the
first trimester of human pregnancy by mechanisms that are
largely unknown, although recent evidence supports the con-
tention that early cytotrophoblast has a bipotential capacity. In
the mouse, withdrawal of FGF4 from TS medium induced tro-
phoblast differentiation, but for our human stem cell lines,
FGF4-supplemented medium was required for cell prolifera-
tion and subsequently allowed differentiation to occur. This
suggests a difference between mouse and human TS cells. The
addition of FGF4 and heparin to early human villous explants
inhibits syncytiotrophoblast regeneration in favour of clumps
of FGF2R-positive cytotrophoblast which can be differentiated
to extravillous cytotrophoblast (Baczyk et al., 2005). The
CTBS cell lines exhibited a similar bipotential differentiation
in culture, such as cell–cell fusion to syncytium, an invasive
implantation into endometrial stroma and terminal differentia-
tion to endovascular cells that expressed HLA-G. Moreover,
following the constitutive expression of eGFP in HESCs, it
was possible to derive a GFP–CTBS cell line to provide unam-
biguous identification in co-culture with other cell types.
Clonally derived HESCs maintain full pluripotency and
proliferation (Amit et al., 2000) suggesting that CTBS cells
develop from a homogeneous HESC population rather than
multiple (i.e. ES and TS) precursors. This finding differs from
Figure 3. Differentiation of cytotrophoblast stem (CTBS) cell line to endovascular cells in ‘trophoblast stem (TS) cells’ conditioned medium.
(A) Phase-contrast micrograph of single adherent cytotrophoblast of CTBS1 cell line; bar = 20 μm. (B) The cells in (A) after 1–2 weeks in cul-
ture. Long aggregates display typical endothelial-like morphology; bar = 15 μm. (C) Dark field, low-power micrograph of culture flask; bar = 100
μm. (D) Phase contrast of endovascular cell aggregate displaying co-expression of (E) HLA-G and (F) platelet endothelial cell adhesion mole-
cule-1 (PECAM-1); bar = 20 μm. (G) Phase contrast of multinucleated ‘giant cells’ near endovascular cell. (H) Endothelial E-cadherin immu-
nolocalization was much greater in giant cells than in endovascular cells; bar = 20 μm. (I) Gene expression (RT–PCR) for endothelial markers in
EBs before selection and after endovascular trophoblasts differentiation from CTBS 1 line.
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the mouse, where trophoblast cells may be derived from the
early embryo and extraembryonic ectoderm (Beddington and
Robertson, 1989) but not from murine ESCs without condi-
tional gene expression (Tanaka et al., 1998; Niwa et al., 2000;
Velkey and O’Shea, 2003). Our cell lines continued prolifera-
tive capacity without HESCs or feeder cells, strongly indicating
the presence of a subpopulation of CTBS. This view was rein-
forced by complete failure of the cell line to revert to HESCs or
pluripotency (other than trophoblast lineage) under permissive
conditions, thereby confirming the absence of any residual
HESCs in the lines and also their restricted developmental
capacity as shown also for mouse TS cells (Tanaka et al.,
1998). The latter can be derived from a cell ‘niche’ that spans
the entire extraembryonic ectoderm and chorionic ectoderm
(Uy et al., 2002), but it remains unclear whether a similar wide
range of trophoblast development supports human TS cells.
The direct developmental progression in vitro would possibly
be the differentiation of HESCs to the immediate trophectoder-
mal stem cell phenotype of the preimplantation blastocyst.
However, the specific routes of derivation of our CTBS lines
still require verification as initial EB formation may induce
various trophoblast cell types from which the cell lines were
ultimately selected. For practical purposes we adopted a rela-
tively simple procedure for selecting viable EBs based on an
appropriate secretory marker (β-HCG), followed by rounds of
enrichment by cell disaggregation and EB regeneration. The
HCG receptor is expressed on invasive cytotrophoblast as well
as syncytiotrophoblast, and similar observations have been
reported for EB differentiation to trophoblast (Gerami-Naini
et al., 2004). The method was effective but did not allow pro-
spective analysis of the differentiation process. Nevertheless,
subsequent antibody and gene profile analyses of the cell lines
using trophoblast-specific markers were consistent with the
derivation of CTBS cells.
Compared with HESCs, mRNA expression for Oct-4, Sox2,
FGF4 and Nanog in CTBS cell lines was absent, but trophob-
last-related mRNAs for Cdx2 (caudal-related homeobox;
Strumpf et al., 2005), HLA-G and Cd9 were up-regulated,
whereas CK7 expression was maintained. The expression
together of the latter three genes is considered as a verification
for extravillous cytotrophoblast (King et al., 2000) which
invades the uterine decidua during placentation (Pijnenborg
et al., 1980; Enders et al., 1997). Surprisingly, eomesodermin
(eomes), a marker of mouse early post-implantation trophob-
last (Russ et al., 2000), was expressed strongly in HESCs but
was weak or absent in the CTBS cells. Several reports have
highlighted differences between mouse and human ESCs
(Henderson et al., 2002; Ginis et al., 2004) including eomeso-
dermin expression in HESCs but not mouse ES cells (Ginis
et al., 2004). Furthermore, the expression of some trophoblast
markers in stock cultures of HESCs may relate to spontaneous
differentiation to trophoblast lineage. We had previously
shown that expression of trophectodermal markers in such
cultures occurred predominantly in the SSEA(–) and
SSEA1(+) subsets of cells, consistent with their expression in
the differentiated derivatives of the HESCs rather than in the
HESCs themselves (Henderson et al., 2002; Ginis et al.,
2004).
Figure 4. Separate image frames from time-lapse movie in a sequence
over approximately 16 h of cell culture of cytotrophoblast stem
(CTBS) cells (CTBS 2 line) showing cell fusion event; bar = 10 μm.
Black arrows indicate direction of movement of cells. (A) Multinucle-
ated cell (on left) comes into proximity with stationary cell on right.
(B) Cell–cell membrane fusion creates cytoplasmic bridge (white
arrow). (C) Both cells retract membranes and granular cytoplasm inter-
mingles. (D) Nuclei aggregate in centre of larger syncytium.
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The differentiation of several trophoblast subtypes in the
cell cultures probably accounts for the physiological
attributes of the CTBS cell to mimic implantation processes
in vitro. Syncytiotrophoblast was readily generated, and the
formation of syncytium by cell–cell fusion was determined
precisely using time-lapse cultures under the microscope.
Two cell lines were initially lost under the prevailing culture
conditions because they rapidly generated syncytium with no
further proliferative capacity, and the proportion of mitoti-
cally active single trophoblast cells was insufficient to sustain
the lines. Whether these lines had a greater propensity to
form syncytium than those that retained proliferative capacity
Figure 5. Cytotrophoblast stem (CTBS) spheroid trophoblast bodies (TBs) in extracellular matrix and endometrial co-culture. (A) TB (CTBS1
cell line) in Matrigel culture for 5 days with long microvilli protrusions of syncytium. Inset (i) and (ii) shows higher magnification phase contrast
and immunostaining displaying cytokeratin 7 (green) and β-HCG (red) in syncytial bed; bar = 100 μm. (B) Separate image frames from sequence
of time-lapse movie (over approximately 48 h) of TB in co-culture with endometrial stromal cells; bar = 150 μm. Black arrows throughout indic-
ate direction of migration of vesicle. (1), white arrow indicates invasive cytotrophoblast outgrowth; (4 and 5), white arrow indicates stromal ero-
sion site; (4) inset (i) and (ii), higher magnification of margin at erosion site showing phase contrast and matrix metalloproteinase (MMP)-2
immunolocalization. (C) CTBS-GFP cells in co-culture with endometrial stroma; bar = 20 μm.
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is not clear. Regular passaging of adherent cells in culture
inhibited syncytium formation, but we are presently investi-
gating culture medium that may inhibit syncytiotrophoblast
while retaining cell proliferation. Such conditions may allow
the rescue of an early trophectodermal stem cell phenotype.
Following extended culture without passaging, CTBS cells
formed the endothelial phenotype of invasive endovascular
cells as displayed by cytotrophoblast from first trimester pla-
cental tissue (Nagamatsu et al., 2004). Previously, the exact
origin of these cells has been in question, but their derivation
from CTBS cell lines provides definitive evidence of their
differentiation from cytotrophoblast. Significantly, although
these cells expressed some markers of endothelial cells, they
lacked expression of vascular endothelial growth factor receptor 1
(flt-1) and exhibited the nonclassical histocompatibility anti-
gen, HLA-G on their surface. Thus, although their morphology
closely resembled that of endothelial cells in culture, they were
clearly a separate phenotype, as determined by biomarkers.
To gain an indication of the physiology of CTBS cells and
their derivatives during implantation events, spheroidal tro-
phoblast bodies, TBs (akin to EBs formed from HESCs) were
generated to resemble the implanting embryo. Matrigel, an
extracellular matrix preparation rich in laminin and collagen,
was used to mimic the endometrial deciduas (Tarrade et al.,
2002; Hemberger et al., 2004) along with human stromal cell
preparations from late luteal phase endometrial biopsy tissue
(Laird et al., 1993). In response to Matrigel culture, TBs exhib-
ited extensive differentiation with projections of endothelial-
like cells, which were cytokeratin 7-positive. Cells within the
body of the TBs expressed HCG. A similar response to
Matrigel has been observed with EBs where a proportion of the
cells differentiate to trophoblast (Gerami-Naini et al., 2004).
Significantly, TBs in co-culture with endometrial stromal cells
exhibited a migration around the culture dish with cycles of
erosion of extracellular matrix followed by reattachment.
Because this co-culture system was essentially two dimen-
sional, the migration of the TB most likely represents a regu-
lated invasion process across the stromal culture rather than
through it. Indeed, a proliferative column of cytotrophoblast
was observed along with the faster migrating endovascular
cells. A similar process of trophoblast invasion has been
observed also for human blastocyst co-culture with stromal
cells in vitro (Carver et al., 2003). During implantation,
cytotrophoblast expresses various zinc-dependent proteolytic
enzymes that cleave constituents of the extracellular matrix
called matrix metalloproteinases (MMPs). A complex interac-
tion with tissue inhibitors of MMPs (TIMPS) ensures a care-
fully controlled regulation of invasion. MMP-2 (gelatinase A)
was identified as a key enzyme correlated with first trimester
invasive capacity of human cytotrophoblast (Huppertz et al.,
1998; Xu et al., 2000; Wang et al., 2001; Staun-Ram et al.,
2004) and activity alters in cytotrophoblast (Campbell et al.,
2004) and plasma of women that develop pre-eclampsia
(Myers et al., 2005). Therefore, immunolocalization of MMP-
2 specifically at the edge of erosion site between TBs and
stroma was good preliminary evidence that the CTBS cells
were secreting physiologically relevant factors. A much more
detailed examination of the mechanisms regulating gene
expression and enzyme activity in this model system is now in
progress.
Overall, these cell lines therefore represent a significant
advance for studies related to human implantation, for example
cell cultures to mimic the early embryo invasion process, or
investigations of placental dysfunctions such as pre-eclampsia.
In the future, somatic nuclear replacement techniques (thera-
peutic cloning) may enable HESCs and subsequently, trophob-
last cell lines to be generated from patients with specific
implantation and placental dysfunctions. Moreover, efficient
generation of endovascular cytotrophoblast may have a wide
utility for regenerative medicine. Their pseudo-vasculogenic
and invasive characteristics might be utilized in a variety of
cell therapies remote from the uterus but related to angiogen-
esis and vessel remodelling, especially as expression of HLA-G
(Kovats et al., 1990) and indoleamine 2,3-deoxygenase
(Mellor et al., 2002) render the cells naturally refractory to
immune rejection.
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